These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2568272)

  • 21. An evaluation of the elevated plus-maze test using the novel anxiolytic buspirone.
    Moser PC
    Psychopharmacology (Berl); 1989; 99(1):48-53. PubMed ID: 2528779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of inflammatory nociception on the anxiolytic-like effect of diazepam and buspirone in rats.
    Fernández-Guasti A; Reyes R; Martínez-Mota L; López-Muñoz FJ
    Psychopharmacology (Berl); 2005 Jul; 180(3):399-407. PubMed ID: 15719217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The alpha 2-adrenoceptor antagonist activity of ipsapirone and gepirone is mediated by their common metabolite 1-(2-pyrimidinyl)-piperazine (PmP).
    Bianchi G; Caccia S; Della Vedova F; Garattini S
    Eur J Pharmacol; 1988 Jul; 151(3):365-71. PubMed ID: 2905658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the alpha 2-adrenoceptor blocking properties of buspirone and ipsapirone in healthy subjects. Relationship with the plasma concentration of the common metabolite 1-(2-pyrimidinyl)-piperazine.
    Berlin I; Chalon S; Payan C; Schöllnhammer G; Cesselin F; Varoquaux O; Puech AJ
    Br J Clin Pharmacol; 1995 Mar; 39(3):243-9. PubMed ID: 7619663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The novel buspirone analogue, 8-[4-[2-(1,2,3,4-tetrahydroisoquinolinyl)[butyl]-8-azaspiro [4.5 ]decane-7,9-dione, with anxiolytic-like and antidepressant-like effects in rats.
    Dereń-Wesołek A; Tatarczyńska E; Chojnacka-Wójcik E
    J Psychopharmacol; 1998; 12(4):380-4. PubMed ID: 10065913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anxiolytic and anxiogenic drug effects on male and female gerbils in the black-white box.
    Bradley BF; Bridges NJ; Starkey NJ; Brown SL; Lea RW
    Behav Brain Res; 2011 Jan; 216(1):285-92. PubMed ID: 20723567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic-pharmacodynamic modeling of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine in rats.
    Zuideveld KP; Rusiç-Pavletiç J; Maas HJ; Peletier LA; Van der Graaf PH; Danhof M
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1130-7. PubMed ID: 12438536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interactions of buspirone with itraconazole and rifampicin: effects on the pharmacokinetics of the active 1-(2-pyrimidinyl)-piperazine metabolite of buspirone.
    Kivistö KT; Lamberg TS; Neuvonen PJ
    Pharmacol Toxicol; 1999 Feb; 84(2):94-7. PubMed ID: 10068153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitory effects of the 5-HT(1A) receptor agonist buspirone on stress-induced hyperglycemia in mice: involvement of insulin and a buspirone metabolite, 1-(2-pyrimidinyl)piperazine (1-PP).
    Sugimoto Y; Takashima N; Noma T; Yamada J
    Biol Pharm Bull; 2005 Apr; 28(4):733-5. PubMed ID: 15802819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of buspirone and its metabolite, 1-(2-pyrimidinyl)piperazine, on brain monoamines and their metabolites in rats.
    Fuller RW; Perry KW
    J Pharmacol Exp Ther; 1989 Jan; 248(1):50-6. PubMed ID: 2521515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 1-(2-Pyrimidinyl)piperazine antagonizes GABA-activated currents in cultured spinal neurones of the rat.
    Smith SM; Hughes D
    Brain Res; 1989 Jul; 493(2):366-7. PubMed ID: 2765902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute and chronic administration of buspirone fails to yield anxiolytic-like effects in a mouse operant punishment paradigm.
    Martin JR; Moreau JL; Jenck F; Cumin R
    Pharmacol Biochem Behav; 1993 Dec; 46(4):905-10. PubMed ID: 7906039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone.
    Harada K; Aota M; Inoue T; Matsuda R; Mihara T; Yamaji T; Ishibashi K; Matsuoka N
    Eur J Pharmacol; 2006 Dec; 553(1-3):171-84. PubMed ID: 17074317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The correlation of the serotonin-positive and anxiolytic activities of nonbenzodiazepine substances].
    Abramets II; Dolzhenko AT; Komissarov IV; Samoĭlovich IM; Talalaenko AN; Kharin NA
    Farmakol Toksikol; 1990; 53(5):13-6. PubMed ID: 1979279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Behavioral studies with anxiolytic drugs. III. Antipunishment actions of buspirone in the pigeon do not involve benzodiazepine receptor mechanisms.
    Barrett JE; Witkin JM; Mansbach RS; Skolnick P; Weissman BA
    J Pharmacol Exp Ther; 1986 Sep; 238(3):1009-13. PubMed ID: 2875168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simultaneous high-performance liquid chromatographic analysis of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine in plasma using electrochemical detection.
    Betto P; Meneguz A; Ricciarello G; Pichini S
    J Chromatogr; 1992 Mar; 575(1):117-21. PubMed ID: 1355487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological properties of SM-3997: a new anxioselective anxiolytic candidate.
    Shimizu H; Hirose A; Tatsuno T; Nakamura M; Katsube J
    Jpn J Pharmacol; 1987 Dec; 45(4):493-500. PubMed ID: 2895201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Buspirone, chlordiazepoxide and diazepam effects in a zebrafish model of anxiety.
    Bencan Z; Sledge D; Levin ED
    Pharmacol Biochem Behav; 2009 Nov; 94(1):75-80. PubMed ID: 19643124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gepirone and 1-(2-pyrimidinyl)-piperazine-induced reduction of aversively evoked ultrasonic vocalisation in the rat.
    Cullen WK; Rowan MJ
    Pharmacol Biochem Behav; 1994 May; 48(1):301-6. PubMed ID: 7913229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential effect of buspirone and diazepam on negative contrast in one-way avoidance learning.
    Torres C; Morales A; Cándido A; Maldonado A
    Eur J Pharmacol; 1995 Jul; 280(3):277-84. PubMed ID: 8566095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.